Curating from trusted global sources…
Curated from trusted global sources, refined into briefing-grade analysis with executive summaries, insights, and bullet-point takeaways.
Candy Kittens founder argues creators win with speed, authenticity, and acquisitions like Graze's £36m deal.
A $670,000-per-charger rollout is BYD’s fastest attempt yet to reshape European charging expectations.
Fortune’s conference panel ties U.S. timing risk to FDA reality, long timelines, and a global AI race.
The BBC is putting Doctor Who out to competitive tender, and Davies claims the “special” was never actually made.
London’s 01Health is turning the clinical platform behind its dental brands into infrastructure other practices can buy.
BYD says it can surpass Toyota by scaling battery advances, fast charging, and overseas production, starting with £1.8bn flash chargers in Europe.
Xi'an UniIC’s DRAM push joins CXMT to monetize China’s memory supercycle, with regulatory timing now front and center.
Libertarian-backed performance drugs meet FDA-only “protocols,” and the fight is really over norms.
A five-person test shows fee math changes by device and timing, and the “why” is basically randomized.
A rare European Commission interim order forces Meta to reopen WhatsApp to competing AI chatbots while antitrust review runs.
Ministry of Finance targets 15 billion yuan in offshore markets, reinforcing Hong Kong’s role for investors shifting currency exposure.
Profit warning ties US airport footfall declines to the Middle East war and triggers a £100m balance-sheet rebuild.
